CME REQUEST & EVALUATION

Title: 7th Annual Updates in the Management and Treatment of Hematologic Malignancies

All questions indicated by * are required.

Participant Information
*Full Name:   *Email:
*Address:
*City:   *State:   *Zip:   *Country:
*Degree/Title: MD/DO PharmD/RPh PA NP RN Other:
ME #:   RN/NP State of License: License #:
*I certify that I completed this CME activity.
The actual amount of time I spent in this activity was
  hours and minutes
*The name and title to display on my CME certificate is:
Participant Demographics
*1. Number of years in practice?   <5 5-10 11-15 16-20 >20 N/A
*2. Type of practice?   Private Hospital Academic N/A
*3. What is your specialty?   Hematology Oncology Pain Management Pediatrics
Primary Care Surgery Other:
Evaluation - Content
*1. After attending this symposium, participants should be able to
- Appraise the role of currently approved and emerging agents in the treatment and maintenance of patients with MM.
  Strongly Agree Agree Neutral Disagree Strongly Disagree
- Utilize recent clinical trial data on emerging therapeutic strategies for Hodgkin lymphoma in order to improve the outcomes of patients with this disease.
  Strongly Agree Agree Neutral Disagree Strongly Disagree
- Assess the clinical activity of current and novel agents for patients with indolent and aggressive B-cell lymphoma.
  Strongly Agree Agree Neutral Disagree Strongly Disagree
- Select effective treatment options for patients with T-cell lymphoma that account for varied patient- and disease-related factors.
  Strongly Agree Agree Neutral Disagree Strongly Disagree
- Evaluate the current clinical data for novel agents and combination therapies under investigation for the treatment of patients with CLL.
  Strongly Agree Agree Neutral Disagree Strongly Disagree
- Propose therapeutic approaches for the treatment of patients with MDS by utilizing data from recent clinical trials.
  Strongly Agree Agree Neutral Disagree Strongly Disagree
- Analyze current data on the safety and efficacy of novel agents and supportive care measures for the management of patients with AML.
  Strongly Agree Agree Neutral Disagree Strongly Disagree
*2. The quality of the educational process (method of presentation and information provided) was satisfactory and appropriate.
Strongly Agree Agree Neutral Disagree Strongly Disagree
*3. The information presented was without promotional or commercial bias.
Strongly Agree Agree Neutral Disagree Strongly Disagree
4. If you answered "disagree" or "strongly disagree" for the above question, please provide specific examples of bias that you perceived in this activity.
*5. The educational activity will result in a change in my practice behavior.
Strongly Agree Agree Neutral Disagree Strongly Disagree
6. Please list two ways you intend to change your practice as a result of this activity.
7. Please assist us in planning future activities by describing any areas in which you feel you have a professional practice gap.
*Please rate the speakers
Excellent Good Neutral Fair Poor N/A
Steven Coutre, MD
Francine Foss, MD
Jerald Radich, MD
S. Vincent Rajkumar, MD

*8. How did you first hear about this activity?   Mailed Invitation Faxed Invitation
Emailed Invitation Publication Ad From a Colleague
*9. The discussion period allowed an appropriate length of time for questions:   Yes   No
Comments:
*10. This meeting was held at a convenient site, time, and date
Strongly Agree Agree Neutral Disagree Strongly Disagree
*11. The meeting room and meeting environment were suitable for this symposium.
Strongly Agree Agree Neutral Disagree Strongly Disagree
*12. Registration for this meeting was efficient and professional
Strongly Agree Agree Neutral Disagree Strongly Disagree
*13. The audio/video was clear and professional
Strongly Agree Agree Neutral Disagree Strongly Disagree
*14. The quality of food/beverage was above average
Strongly Agree Agree Neutral Disagree Strongly Disagree
*15. The overall program met my personal expectations
Strongly Agree Agree Neutral Disagree Strongly Disagree
*16. Based on your previous knowledge and experience, the level of the program was
Too Basic Appropriate Too Complex
*17. Funding for this conference has been provided through an unrestricted educational grant from commercial supporter(s). Do you feel you were adequately informed of commercial support or potential faculty conflict of interest?   Yes No
*18. Would you be interested in participating in future programs:   Yes No
*19. Which format do you prefer (please check all that apply):
Audio teleconference Satellite broadcast Symposium Monograph
Home study audiotape Home study videotape Internet
20. Please provide us with suggestions for improving this activity
21. Additional comments: